IDO2 Antibody (IDO2/2639) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14051H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin, Protein Array
Label
HRP
Antibody Source
Monoclonal Mouse IgG Kappa Clone # IDO2/2639
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for IDO2 Antibody (IDO2/2639) [HRP]
Immunogen
Recombinant fragment (around aa 200-350) of human IDO2 protein (exact sequence is proprietary) (Uniprot: Q6ZQW0)
Localization
Cytoplasm
Clonality
Monoclonal
Host
Mouse
Isotype
IgG Kappa
Applications for IDO2 Antibody (IDO2/2639) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Protein Array
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IDO2
Long Name
Indoleamine 2,3-dioxygenase 2
Alternate Names
Ido-2, INDOL1, Indoleamine 2,3-dioxygenase-2
Gene Symbol
IDO2
Additional IDO2 Products
Product Documents for IDO2 Antibody (IDO2/2639) [HRP]
Product Specific Notices for IDO2 Antibody (IDO2/2639) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...